James Komianos, PhD, is a Senior Scientist at Deep Origin, a drug discovery biotech formed through its merger with BiosimAI. His expertise spans computational biophysics, cellular simulations, and methods for modeling active matter and the cytoskeleton, underpinned by extensive experience building high-performance simulation software and applying advanced statistical and machine learning methods. He previously worked in quantiative finance roles at Capital One and The Oakleaf Group creating predictive models for fixed income and credit portfolios, and conducted computational biophysics research at the University of Maryland during his PhD, where he developed stochastic, spatially resolved models for protein networks and actin dynamics.
.png)
.png)